[The disseminated intravascular coagulation syndrome and infection].
The disseminated intravascular coagulation syndrome (1) Definition. History. (2) Etiopathogeny of the disseminated intravascular coagulation syndrome. (3) The clinical and laboratory diagnosis of the disseminated intravascular coagulation syndrome. (4) The principal infections in which the disseminated intravascular coagulation syndrome has been described: bacterial, viral, rickettsial, parasitic, mycotic. (5) Treatment of the disseminated intravascular coagulation syndrome.
D000614:Aminocaproates / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000627:therapeutic use; D001424:Bacterial Infections / Q000150:complications*; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy / Q000209:etiology*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D009181:Mycoses / Q000150:complications*; D010272:Parasitic Diseases / Q000150:complications*; D012282:Rickettsia Infections / Q000150:complications; D014777:Virus Diseases / Q000150:complications*
D000614:Aminocaproates; D000900:Anti-Bacterial Agents; D005343:Fibrinolytic Agents; D006493:Heparin; D007611:Aprotinin
Sindromul de coagulare intravasculară diseminată şi infecţia